Matthew Vincent Dolan - EVP Strategy and Corporate Dev at Dexcom Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Strategy and Corporate Dev
Stock Symbol
DXCM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

Matthew Vincent Dolan - trading volume in the past year for Dexcom Inc

Holdings reported by Matthew Vincent Dolan for Dexcom Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 40,075 $5.07 M $126.58 May 15, 2024 Direct

Transactions reported by Matthew Vincent Dolan for Dexcom Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership